Catalent (CTLT) stock rises on reports of imminent $16.5 billion sale to Novo Holdings with FTC approval and EU Commission ...

Robert W. Baird has recently raised Catalent Inc (CTLT) stock to Outperform rating, as announced on November 16, 2023, according to Finviz. Earlier, on September 5, 2023, Argus had raised the stock ...

Highlights,State Street Corp increased its stake in Catalent by 1.5% in Q3.,Catalent reported a slight miss on earnings in ...

Novo Holdings’ $16.5 billion takeover of US contract development and manufacturing organisation (CDMO) Catalent does not ...

The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of ...

Novo Holdings, which owns a controlling stake in Wegovy-maker Novo Nordisk, agreed to buy Catalent in February for $16.5 billion, including debt. In turn, Novo Holdings will flip three of the most ...

Novo Holdings, which owns a controlling stake in Wegovy-maker Novo Nordisk, agreed to buy Catalent in February for $16.5 billion, including debt. In turn, Novo Holdings will flip three of the most ...

As the clock ticks down on 2024, Novo Holdings’ proposed $16.5 billion buyout of CDMO giant Catalent—which the companies have ...

The European Commission has approved unconditionally, under the EU Merger Regulation, the proposed acquisition of Catalent (CTLT) by Novo ...

Catalent (CTLT) and Novo Holdings announced that the European Commission has granted unconditional approval for the pending transaction under ...

Andy Rathmann-Noonan, who has served as President with remarkable dedication, will transition into a new role on the NSTMF Board of Directors. Under Rathmann-Noonan's visionary leadership, the ...

The Honourable Mark Holland, Federal Minister of Health, today tabled the 2023 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the Senate and the House of Commons ...